Patent Assignment
Reel/Frame 041752/0004
Assignment of Assignor's Interest
Recorded: 2017-03-27
Pages: 5
Assignors
GRAHN, AMY
Executed: 2016-08-30
SHERMAN, JEFFREY W.
Executed: 2016-08-08
DEVANE, JOHN GERARD
Executed: 2016-08-04
Assignee
HZNP LIMITED
21 LAFFAN STREET, HAMILTON PEMBROKE, HM09, BERMUDA
Covered Properties
(3)
Combination of Immunomodulatory Agent with Pd-1-or Pd-L1 Checkpoint Inhibitors in the Treatment of Cancer
PCT:
PCT/US2016/043289 ↗
COMBINATION OF IMMUNOMODULATORY AGENT WITH PD-1 or PD-L1 CHECKPOINT INHIBITORS IN THE TREATMENT OF CANCER
Application:
15/216,585 →
Publication:
US 2017/0021019
COMBINATION OF IMMUNOMODULATORY AGENT WITH PD-1 or PD-L1 CHECKPOINT INHIBITORS IN THE TREATMENT OF CANCER
Application:
62/195,461 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 27, 2017
From: ZIBELMAN, MATTHEW; PLIMACK, ELIZABETH
To: THE AMERICAN ONCOLOGIC HOSPITAL - D/B/A HOSPITAL OF THE FOX CHASE CANCER CENTER
Reel/Frame 041752/0335 →
Security Agreement
Oct 24, 2018
From: HORIZON PHARMA RHEUMATOLOGY LLC; HZNP LIMITED; HORIZON THERAPEUTICS, LLC
To: CITIBANK, N.A.
Reel/Frame 047720/0068 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.); HZNP LIMITED; HORIZON THERAPEUTICS U.S. HOLDING LLC (SUCCESSOR IN INTEREST TO HORIZON THERAPEUTICS, LLC)
Reel/Frame 065154/0075 →